Industry News

Medical Device Industry News

American Gastroenterological Association Clinical Practice Update States That TissueCypher May Be Beneficial for Risk-Stratification of Patients with Non-Dysplastic Barrett’s Esophagus

August 4th, 2022|Medical Device News Magazine|

The TissueCypher Barrett’s Esophagus test is Castle’s precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barrett’s esophagus (BE).